Landete José Maria
a Departamento De Tecnología De Alimentos , Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria (INIA) , Madrid , Spain.
Crit Rev Biotechnol. 2017 May;37(3):296-308. doi: 10.3109/07388551.2016.1144044. Epub 2016 Feb 26.
Lactic acid bacteria (LAB) have a long history of use in fermented foods and as probiotics. Genetic manipulation of these microorganisms has great potential for new applications in food safety, as well as in the development of improved food products and in health. While genetic engineering of LAB could have a major positive impact on the food and pharmaceutical industries, progress could be prevented by legal issues related to the controversy surrounding this technology. The safe use of genetically modified LAB requires the development of food-grade cloning systems containing only the DNA from homologous hosts or generally considered as safe organisms, and not dependent antibiotic markers. The rationale for the development of cloning vectors derived from cryptic LAB plasmids is the need for new genetic engineering tools, therefore a vision from cryptic plasmids to applications in food-grade vectors for LAB plasmids is shown in this review. Replicative and integrative vectors for the construction of food-grade vectors, and the relationship between resistance mechanism and expression systems, will be treated in depth in this paper. Finally, we will discuss the limited use of these vectors, and the problems arising from their use.
乳酸菌(LAB)用于发酵食品和作为益生菌已有很长的历史。对这些微生物进行基因操作在食品安全、改进食品产品开发以及健康领域具有巨大的新应用潜力。虽然乳酸菌的基因工程可能会对食品和制药行业产生重大积极影响,但围绕该技术的争议所涉及的法律问题可能会阻碍进展。安全使用转基因乳酸菌需要开发仅包含来自同源宿主或通常被视为安全生物体的DNA且不依赖抗生素标记的食品级克隆系统。开发源自隐秘乳酸菌质粒的克隆载体的基本原理是需要新的基因工程工具,因此本综述展示了从隐秘质粒到用于乳酸菌质粒的食品级载体应用的愿景。本文将深入探讨用于构建食品级载体的复制型和整合型载体,以及抗性机制与表达系统之间的关系。最后,我们将讨论这些载体的有限用途以及使用它们所产生的问题。